TrialInternational journal of radiation oncology, biology, physics2016

IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.

David B Landau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.